Table 1 Profile and distribution of isolated bacteria from medical equipment
Bacterial isolates
|
Stethoscope parts
|
Thermometers
|
Sphygnometers
|
Mattresses (n=6)
|
Bedsides
|
Computers
|
CS table (n=15)
|
Total
|
Ear(n=25)
|
Tubing (n=17)
|
Diaphragm (n=19)
|
TM (n=6)
|
TS (n=6)
|
SC (n=10)
|
SB (n=8)
|
BTT (n=10)
|
BTB (n=9)
|
CM (n=7)
|
CE (n=10)
|
CS (n=9)
|
Adult ICU
|
|
CoNS
|
4
|
3
|
6
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
24
|
S.aureus
|
7
|
4
|
3
|
0
|
0
|
2
|
1
|
2
|
2
|
1
|
0
|
2
|
1
|
2
|
27
|
K.pneumonia
|
0
|
0
|
1
|
0
|
1
|
2
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
6
|
E.coli
|
1
|
0
|
2
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
Total
|
12
|
7
|
12
|
1
|
1
|
4
|
3
|
3
|
4
|
4
|
2
|
4
|
2
|
4
|
63
|
Pediatric ICU
|
|
CoNS
|
1
|
1
|
0
|
0
|
0
|
3
|
1
|
2
|
1
|
2
|
0
|
0
|
2
|
2
|
15
|
S.aureus
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
2
|
0
|
0
|
10
|
C.fraundii
|
3
|
3
|
2
|
2
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
14
|
E.aerogens
|
1
|
1
|
1
|
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
S. typhi
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
2
|
P.vulgaris
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
E.coli
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
5
|
Total
|
7
|
7
|
4
|
2
|
2
|
6
|
5
|
3
|
6
|
5
|
2
|
2
|
3
|
3
|
57
|
Neonatal ICU
|
|
CoNS
|
3
|
2
|
3
|
3
|
2
|
NA
|
NA
|
NA
|
NA
|
NA
|
2
|
2
|
1
|
3
|
21
|
S.aureus
|
1
|
1
|
0
|
0
|
1
|
NA
|
NA
|
NA
|
NA
|
NA
|
1
|
0
|
2
|
3
|
9
|
C.fraundii
|
1
|
0
|
0
|
0
|
0
|
NA
|
NA
|
NA
|
NA
|
NA
|
0
|
0
|
0
|
0
|
1
|
K.pneumonia
|
1
|
0
|
0
|
0
|
0
|
NA
|
NA
|
NA
|
NA
|
NA
|
0
|
1
|
1
|
2
|
5
|
Total
|
6
|
3
|
3
|
3
|
3
|
NA
|
NA
|
NA
|
NA
|
NA
|
3
|
3
|
4
|
8
|
36
|
BTB; Bedside Table Bottom, BTT; Bedside Table Top, CE; computer Enter key, CM; computer mouse, CoNs; coagulase negative staphylococcus, CSTable ; computer standing table, CS; computer space bar, Diaphragm; Stethoscope diaphragm, Ear; Stethoscope ear piece, NA; none applicable, TM; Thermometer mercury, TS; Thermometer side, SB; Sphygmomanometer bulb, SC; Sphygmomanometer cuff, Tubing;Stethoscope tubing
Table 2 Antimicrobial susceptibility pattern of gram positives and negative from the medical inanimate surfaces
Isolates (N)
|
Pattern
|
E
|
P
|
AMC
|
CIP
|
CTR
|
TE
|
C
|
GEN
|
AMP
|
CX
|
Total (%)
|
CoNS (60)
|
S
|
20 (33.3)
|
24(40)
|
22(37.2)
|
46(44)
|
34(57.6)
|
52(88.1)
|
41(72.8)
|
50(83)
|
4(6.7)
|
NA
|
47.4
|
I
|
10 (16.7)
|
1(1.7)
|
0
|
5(8.4)
|
14(22)
|
0
|
4(6.7)
|
4(6.7)
|
0
|
NA
|
6.7
|
R
|
30 (50)
|
35(53.3)
|
38(62.7)
|
9(13.5)
|
12(20.3)
|
8(11.8)
|
15(23.7)
|
6(10.1)
|
56(93.2)
|
NA
|
42.5
|
S.aurues (46)
|
S
|
8 (17.4)
|
9(19.5)
|
17(36.9)
|
31(67.4)
|
19(41.3)
|
36(78.2)
|
31(67.4)
|
35(76)
|
5(10.8)
|
12(26.1)
|
40.5
|
I
|
15 (32.6)
|
3(6.5)
|
0
|
4(8.6)
|
14(30.4)
|
3(6.5)
|
3(6.5)
|
1(2.1)
|
0
|
0
|
8.8
|
R
|
23 (50)
|
34(73.9)
|
29(63)
|
11(23.9)
|
13(28.2)
|
7(15.2)
|
12(26)
|
10(21.7)
|
41(89.1)
|
34(73.9)
|
50.5
|
Total (106)
|
S
|
28(26.4)
|
33(31.1)
|
39(36.8)
|
77(72.6)
|
53(50)
|
88(83)
|
75(70.8)
|
85(80.2)
|
9(8.5)
|
12(26.1)
|
44.9
|
I
|
25(23.6)
|
4(3.8)
|
0
|
9(8.5)
|
28(26.4)
|
3(2.8)
|
7(6.6)
|
5(4.7)
|
0
|
0
|
7.4
|
R
|
53(50)
|
69(65.1)
|
67(63.2)
|
20(18.9)
|
25(23.6)
|
15(14.2)
|
26(24.5)
|
16(15.1)
|
97(91.5)
|
34(73.9)
|
47.9
|
Isolates
|
Pattern
|
AMC
|
CIP
|
CTR
|
TE
|
C
|
GEN
|
AMP
|
CTX
|
NA
|
AK
|
Total (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C. fraundii(15)
|
S
|
0
|
14(93.3)
|
15(100)
|
14(93.3)
|
15(100)
|
15(100)
|
2(13.3)
|
15(100)
|
0
|
12(80)
|
68
|
I
|
2(13.3)
|
0
|
0
|
1(6.6)
|
0
|
0
|
1(6.6)
|
0
|
0
|
0
|
2.6
|
R
|
13(86.6)
|
1(6.6)
|
0
|
0
|
0
|
0
|
12(80)
|
0
|
15(100)
|
3(20)
|
29.3
|
K.pnumoniae (11)
|
S
|
0
|
9(81.8)
|
4(36.3)
|
6(54.5)
|
5(33.3)
|
11(100)
|
1(9)
|
2 (18.1)
|
2 (18.1)
|
8(72.7)
|
42.3
|
I
|
1(9)
|
1(9)
|
1(9)
|
2(18.1)
|
1(9)
|
0
|
0
|
0
|
4(36.3)
|
2(18.1)
|
10.8
|
R
|
10(90.9)
|
1(9)
|
6(54.5)
|
3(27.2)
|
5(45.4)
|
0
|
10(90.9)
|
9(100)
|
5(45.4)
|
1(9)
|
47.2
|
E.aerogens(9)
|
S
|
0
|
8(88.9)
|
9(100)
|
9(100)
|
9(100)
|
9(100)
|
0
|
9(100)
|
0
|
8(88.9)
|
67.8
|
I
|
6(66.6)
|
1(11.1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7.8
|
R
|
3(33.3)
|
0
|
0
|
0
|
0
|
0
|
9(100)
|
0
|
9(100)
|
1(11.1)
|
24.4
|
P.vulgaris(2)
|
S
|
0
|
2(100)
|
1(50)
|
1(50)
|
2(100)
|
2(100)
|
0
|
1(50)
|
2(100)
|
2(100)
|
65
|
I
|
1(50)
|
0
|
0
|
0
|
0
|
0
|
0
|
1(50)
|
0
|
0
|
10
|
R
|
1(50)
|
0
|
1(50)
|
1(50)
|
0
|
0
|
2(100)
|
0
|
0
|
0
|
25
|
E.coli(11)
|
S
|
0
|
8(72.7)
|
3(27.3)
|
6(50)
|
8(72.7)
|
7(63.75)
|
3(25)
|
3(27.3)
|
3(27.3)
|
4(36.4)
|
40.2
|
I
|
2(18.2)
|
1(9.1)
|
0
|
2(18.2)
|
0
|
3(27.3)
|
0
|
0
|
1(9.1)
|
5(45.4)
|
12.3
|
R
|
9(81.8)
|
2(18.2)
|
8(72.7)
|
3(27.3)
|
3(27.3)
|
1(9.1)
|
8(72.7)
|
8(72.7)
|
7(63.7)
|
2(18.2)
|
46.4
|
Total (48)
|
S
|
0
|
42(84)
|
33(66)
|
39(78)
|
41(82)
|
45(90)
|
7(14)
|
30(60)
|
7(14)
|
35(70)
|
55.8
|
I
|
13(26)
|
4(8)
|
1(2)
|
4(8)
|
1(2)
|
4(8)
|
1(2)
|
2(4)
|
5(10)
|
8(16)
|
8.6
|
R
|
37(74)
|
4(8)
|
16(32)
|
7(14)
|
8(16)
|
1(2)
|
42(84)
|
18(36)
|
38(76)
|
7(14)
|
35.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AMC; Amoxicillin-clavulanic, AMP; Ampicillin, CX; Cefoxitin, CRT; Ceftriaxone, C; Chloramphenicol, CIP; Ciprofloxacin, CoNS; coagulase negative staphylococcus, E; Erythromycin, GEN; Gentamicin, I; intermediate, P; Penicillin G, R; resistant, S; sensitive, TE; Tetracycline,
Table 3 Multidrug resistant (MDR) pattern of isolated bacteria from medical equipments and inanimate surfaces
Bacterial Species
|
Resisted antimicrobial agents
|
No. bacteria
( % ) for MDR
|
Bacterial Species
|
Resisted antimicrobial agents
|
No. bacteria
( % ) for MDR
|
No.
|
Type
|
No.
|
Type
|
Coagulase negative staphylococcus
|
R4
|
E, AMC, CIP, AMP
|
1(1.7)
|
S.aurues
|
R3
|
CIP,GEN, AMP
|
1(2.2)
|
R5
|
E,P, AMC,C, AMP
|
3(5)
|
E, AMP, CX
|
1(2.2)
|
p, AMC,C,GEN, AMP
|
2(3.3)
|
R4
|
E,P, AMP, CX
|
4(8.7)
|
p, AMC,CIP, TE, AMP
|
2(3.3)
|
AMC,C, AMP, CX
|
1(2.2)
|
E, AMC, CIP, TE, AMP
|
1(1.7)
|
R5
|
P, AMC,C, AMP, CX
|
1(2.2)
|
E,P, CIP,C, AMP
|
1(1.7)
|
E,P, AMC, AMP, CX
|
3(6.5)
|
R6
|
E,P, AMC,C, CTR, AMP
|
2(3.3)
|
P, AMC, CTR, AMP, CX
|
1(2.2)
|
E,P, AMC, CTR,GEN, AMP
|
1(1.7)
|
R6
|
P, CIP, CTR,C, AMP, CX
|
1(2.2)
|
E,P, AMC, CTR,C, AMP
|
1(1.7)
|
E,P, AMC, CTR, AMP, CX
|
1(2.2)
|
R7
|
E,P, AMC, CTR, TE,C, AMP
|
1(1.7)
|
E,P, AMC,C, AMP, CX
|
2(4.3)
|
E,P, AMC, CIP,CTR,GEN, AMP
|
1(1.7)
|
E, AMC, C,GEN, AMP, CX
|
1(2.2)
|
R9
|
E,P, AMC, CIP,CTR, TE,C,GEN, AMP
|
2(3.3)
|
R7
|
E,P, AMC, CTR,C, AMP, CX
|
2(4.3)
|
Total
|
|
17(28.3)
|
p, AMC, CIP, CTR,GEN,AMP, CX
|
3(6.5)
|
E.coli
|
R3
|
CTR,CTX,AK
|
1(9.1)
|
E,P, CIP, CTR,C, AMP,CX,
|
1(2.2)
|
R5
|
AMC, CTR, AMP,CTX,NA
|
2(18.2)
|
E,P, AMC, TE,C, AMP, CX
|
1(2.2)
|
AMC, CTR, AMP,CTX,AK
|
1(9.1)
|
R8
|
E,P, AMC, CIP, TE,GEN, AMP, CX
|
1(2.2)
|
AMC, CTR,C, AMP,CTX
|
1(9.1)
|
R9
|
E,P, AMC, CIP, CTR, TE,GEN, AMP, CX
|
2(4.3)
|
R6
|
AMC,CIP, CTR,C,CTX, NA
|
1(9.1)
|
R10
|
E,P, AMC,CIP,CTR,TE,C,GEN, AMP, CX
|
1(2.2)
|
R7
|
AMC, CTR, TE,C, AMP,CTX, NA
|
1(9.1)
|
Total
|
|
27(58.7)
|
R9
|
AMC,CIP, CTR, TE,C,GEN, MP,CTX,NA
|
1(9.1)
|
C.fraundii
|
R4
|
AMC, AMP, NA, AK
|
3(20)
|
Total
|
|
8(72.7)
|
Total
|
|
3(20)
|
P; penicillin, CX; cefoxitin, E; erythromycin, AMC; amoxicillin-clavulanic acid, AMP; ampicillin, CTR; ceftriaxone, CIP; ciprofloxacin, C; chloramphenicol, GEN; gentamicin, TE; tetracycline, AK; amikacin, CTX; cefotaxime, NA; Nalidixic acid, R3; R4; R5; R6; R7; R8; R9; R10; R11; resistant to ( 3, 4, 5, 6, 7, 8, 9, 10, 11 antimicrobial agents), respectively, MDR; non- susceptible to ≥1 agent in ≥3 antimicrobial categories